ARTICLE | Company News
Evotec, Rigel service deal
October 2, 2001 7:00 AM UTC
Evotec OAI (NMarkt:EVT) will use its drug discovery platform to select and synthesize lead compounds for RIGL. The small molecule leads will be screened against RIGL's ubiquitin ligases to identify ch...